Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$954M |
| 2 |
Salesforce
CRM
|
+$683M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$620M |
| 4 |
HCA Healthcare
HCA
|
+$560M |
| 5 |
Netflix
NFLX
|
+$445M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$861M |
| 2 |
Incyte
INCY
|
+$755M |
| 3 |
NVIDIA
NVDA
|
+$655M |
| 4 |
Charles Schwab
SCHW
|
+$534M |
| 5 |
MetLife
MET
|
+$373M |
Sector Composition
| 1 | Financials | 19.84% |
| 2 | Technology | 15.57% |
| 3 | Industrials | 8.44% |
| 4 | Healthcare | 8.44% |
| 5 | Energy | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5451
Outdoor Holding Company Common Stock
POWW
$178M
| $30K | ﹤0.01% |
13,805
+4,785
| +53% | +$10.4K |
|
5452
Avita Medical
RCEL
$123M
| $30K | ﹤0.01% |
1,709
+620
| +57% | +$10.9K |
|
5453
Summit Therapeutics
SMMT
$14.1B
| $30K | ﹤0.01% |
12,148
+11,524
| +1,847% | +$28.5K |
|
|
SPE
5454
Special Opportunities Fund
SPE
$169M
| $30K | ﹤0.01% |
2,711
+341
| +14% | +$3.77K |
|
|
LOGC
5455
DELISTED
ContextLogic
LOGC
| $30K | ﹤0.01% |
4,588
+317
| +7% | +$2.07K |
|
|
PTRA
5456
DELISTED
Proterra Inc. Common Stock
PTRA
| $30K | ﹤0.01% |
24,493
-18,483
| -43% | -$22.6K |
|
5457
Cohen & Co
COHN
$24M
| $29K | ﹤0.01% |
7,097
-4,424
| -38% | -$18.1K |
|
5458
Caesarstone
CSTE
$48.4M
| $29K | ﹤0.01% |
5,574
-1,856
| -25% | -$9.66K |
|
5459
Viant Technology
DSP
$158M
| $29K | ﹤0.01% |
6,386
+3,050
| +91% | +$13.9K |
|
5460
Middlefield Banc Corp
MBCN
$245M
| $29K | ﹤0.01% |
+1,071
| New | +$29K |
|
|
MESO
5461
Mesoblast
MESO
$1.9B
| $29K | ﹤0.01% |
3,829
| – | – |
|
5462
NN Inc
NNBR
$117M
| $29K | ﹤0.01% |
12,116
-176,643
| -94% | -$423K |
|
5463
Ponce Financial Group
PDLB
$336M
| $29K | ﹤0.01% |
3,254
+3,239
| +21,593% | +$28.9K |
|
5464
Quantum-Si Incorporated
QSI
$239M
| $29K | ﹤0.01% |
15,861
+10,751
| +210% | +$19.7K |
|
5465
Sutro Biopharma
STRO
$74.3M
| $29K | ﹤0.01% |
6,275
+2,289
| +57% | +$10.6K |
|
5466
Unisys
UIS
$282M
| $29K | ﹤0.01% |
7,174
+3,428
| +92% | +$13.9K |
|
5467
Advantage Solutions
ADV
$619M
| $28K | ﹤0.01% |
12,000
+3,731
| +45% | +$8.71K |
|
|
AFMD
5468
DELISTED
Affimed
AFMD
| $28K | ﹤0.01% |
4,631
-2,104
| -31% | -$12.7K |
|
5469
Atomera
ATOM
$106M
| $28K | ﹤0.01% |
3,210
+1,636
| +104% | +$14.3K |
|
5470
Cardiff Oncology
CRDF
$136M
| $28K | ﹤0.01% |
19,299
+317
| +2% | +$460 |
|
|
DGICB
5471
Donegal Group Class B
DGICB
$606M
| $28K | ﹤0.01% |
2,022
| – | – |
|
5472
EPR Properties 9.00% Series E Cumulative Convertible Preferred Shares
EPR.PRE
$111M
| – | – |
0
| – | -$45K |
|
5473
Fennec Pharmaceuticals
FENC
$244M
| $28K | ﹤0.01% |
3,182
+2,758
| +650% | +$24.3K |
|
5474
Forge Global Holdings
FRGE
$239M
| $28K | ﹤0.01% |
+764
| New | +$28K |
|
5475
GrowGeneration
GRWG
$103M
| $28K | ﹤0.01% |
8,374
-116,632
| -93% | -$390K |
|